Tumors containing p53 mutations exhibit a high degree of genomic instability associated with tumor progression and invasion by upregulation of p53-mutant target genes, and the TP53 mutation is well known for its prognostic impact in endometrial carcinoma (Stelloo et al., 2016). The gene discussed is TP53; the disease is endometrial carcinoma.